๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cisplatin-based chemotherapy in a renal transplant recipient

โœ Scribed by Celeste M. Lindley; Teressa R. Gordon; Stephen J. Tremont

Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
576 KB
Volume
68
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Cisplatin-based chemotherapy in renal tr
Cisplatin-based chemotherapy in renal transplant recipients: A case report and a review of the literature
โœ Vladimir I. Benisovich; Lewis Silverman; Robert Slifkin; Nelson Stone; Elliot Co ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 376 KB ๐Ÿ‘ 2 views

## BACKGROUND. Renal transplant recipients have a high incidence of cancer. The main side effect of cisplatin, nephrotoxicity, has special implications in renal transplant recipients. This is particularly true in view of the routine use of cyclosporine as an inimunosuppresant. Nephrotoxicity is als

Erythroleukemia in a renal transplant re
Erythroleukemia in a renal transplant recipient
โœ John A. Ellerton; George A. Deveber; Michael A. Baker ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 234 KB ๐Ÿ‘ 3 views

A 53-year-old male developed acute erythroleukemia three years after renal transplantation. He had received three years of immunosuppressive therapy with azathioprine. A preleukemic phase associated with chromosome abnormalities was recognized. Azathioprine has been associated with chromosome abnorm